⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 15, 2024Open Access

Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

Lena Fischer‐Riepe Sareetha Kailayangiri Katharina Zimmermann Rita Pfeifer Michael Aigner Bianca Altvater Sascha Kretschmann Simon Völkl Jordan Hartley Celine Dreger Katja Petry Andreas Bosio Angelika von Döllen Wolfgang Hartmann Holger N. Lode Dennis Görlich Andréas Mackensen Melanie Jungblut Axel Schambach Hinrich Abken Claudia Rössig

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Absolute numbers of T cells and IL-18 concentrations during manufacturing

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Fischer‐Riepe et al. (2024) studied this question.

synapsesocial.com/papers/68e5c1f0b6db643587559986 https://doi.org/10.1158/1078-0432.26711190

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers2024
2Supplementary Methods S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers2024
3Supplementary Methods S1 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers2024
4Supplementary Figure S3 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers2024
5Supplementary Figure S2 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers2024

Supplementary Figure S2 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers2024
Data from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers2024
Abstract 6328: Preclinical development of CAR T cells with antigen-inducible IL-18 enforcement to treat GD2-positive solid cancers2024